The world's biggest vaccine maker is stalling on exports. That's a problem for the planet's most vulnerable

As India's own coronavirus crisis has spiraled, SII -- world's largest vaccine maker -- can no longer export its goods. Last week, the SII said it wouldn't restart deliveries to COVAX, a worldwide initiative aimed at distributing vaccines to countries regardless of wealth, until the end of this year. While SII's decision will be a lifeline for India, which is still reporting about 200,000 new cases a day, the delay poses a huge problem for developing countries that depend on COVAX to control large outbreaks of their own. The world is already 140 million doses short -- and by the end of June, that gap will have reached 190 million shots, the United Nations children's agency, one of the partners in COVAX, said last week. There is currently no timeframe for resolving the shortage, UNICEF said.